Report cover image

NASH Drug Pipeline and Market Overview

Publisher Kalorama Information
Published Jan 06, 2020
Length 18 Pages
SKU # KLI16143204

Description

NASH Drug Pipeline and Market Overview

Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by inflammation in the liver and liver cell damage, which can lead to scarring of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment of this disease in terms of developer, type of drug, phase study, and market entrance estimate. In addition, the report provides the following data:
  • Estimated Treatment Cost for NASH Therapies, Low-, Mid-, High-Range, 30-day Supply
  • NASH Market Estimates by Global Region, 2025 Forecast (United States & Canada, EMEA, Latin America, Asia Pacific)
In creating its market forecast, Kalorama discusses the indicators that needed to be evaluated to create this estimate, commenting on:
  • NASH Disease Incidence and Prevalence
  • NAFLD Incidence and Prevalence
  • Risk Factor Evaluation
  • Pricing Trends
  • Liver Transplant Statistics and Trends
  • Expected Market Penetration
  • Global Treatment Options and Emerging Therapies
NASH Drug Pipeline and Market Overview also covers the competitive outlook in the NASH treatment market, noting the activities of the current major players, which include:
  • Intercept
  • Genfit
  • Allergan
  • Madrigal
  • Immuron
  • Galectin
  • Gilead

*Note: The full report pricing option allows for 1-10 users in a single department*

Table of Contents

18 Pages
    • Introduction
    • Market Summary
    • Competitive Summary
    • Overview
    • Introduction
    • Products in Development
    • Overview
    • Market Forecast Indicators
    • Competitive Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us